The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
The Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Immunity. 2021 May 11;54(5):875-884. doi: 10.1016/j.immuni.2021.04.004.
Myeloid-derived suppressor cells (MDSCs) are one of the most discussed biological entities in immunology. While the context and classification of this group of cells has evolved, MDSCs most commonly describe cells arising during chronic inflammation, especially late-stage cancers, and are defined by their T cell immunosuppressive functions. This MDSC concept has helped explain myeloid phenomena associated with disease outcome, but currently lacks clear definitions and a unifying framework across pathologies. Here, we propose such a framework to classify MDSCs as discrete cell states based on activation signals in myeloid populations leading to suppressive modes characterized by specific, measurable effects. Developing this level of knowledge of myeloid states across pathological conditions may ultimately transform how disparate diseases are grouped and treated.
髓系来源的抑制性细胞(MDSCs)是免疫学中讨论最多的生物实体之一。尽管该细胞群的背景和分类已经发生了演变,但 MDSCs 最常用于描述在慢性炎症,尤其是晚期癌症中出现的细胞,并因其 T 细胞免疫抑制功能而被定义。MDSC 概念有助于解释与疾病结果相关的骨髓现象,但目前缺乏明确的定义和跨病理学的统一框架。在这里,我们提出了这样一个框架,根据导致抑制模式的髓系群体中的激活信号将 MDSC 分类为离散的细胞状态,抑制模式的特征是具有特定的、可测量的作用。在病理条件下发展出对骨髓状态的这种水平的了解,最终可能会改变不同疾病的分组和治疗方式。